Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MERCHANT, R. E")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2
Export

Selection :

  • and

The effects of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on glioma-specific cytotoxic T-cell activity in Fischer 344 ratsRICE, C. D; MERCHANT, R. E; TAE CHEONG JEONG et al.Toxicology (Amsterdam). 1995, Vol 95, Num 1-3, pp 177-185, issn 0300-483XArticle

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytesMERCHANT, R. E; ELLISON, M. D; YOUNG, H. F et al.Journal of neuro-oncology. 1990, Vol 8, Num 2, pp 173-188, issn 0167-594X, 16 p.Article

Glioma proliferation modulated in vitro by isothermal radiofrequency radiation exposureCLEARY, S. F; LI-MING LIU; MERCHANT, R. E et al.Radiation research. 1990, Vol 121, Num 1, pp 38-45, issn 0033-7587Article

Sterile abscesses in glioma patients treated by intraparenchymal injection of lymphokine-activated killer cells and recombinant interleukin-2 (case reports)ATKINSON, L. L; MERCHANT, R. E; GHATAK, N. R et al.Neurosurgery. 1989, Vol 25, Num 5, pp 805-810, issn 0148-396XArticle

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumorMERCHANT, R. E; MERCHANT, L. H; COOK, S. H. S et al.Neurosurgery. 1988, Vol 23, Num 6, pp 725-732, issn 0148-396XArticle

Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 ratsGRAF, M. R; MERCHANT, R. E.Journal of neuro-oncology. 1999, Vol 45, Num 3, pp 209-218, issn 0167-594XConference Paper

Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-α in the ratWRIGHT, J. L; MERCHANT, R. E.Acta neuropathologica. 1992, Vol 85, Num 1, pp 93-100, issn 0001-6322Article

Cerebral vasomotor responses after recombinant interleukin 2 infusionELLISON, M. D; KRIEG, R. J; MERCHANT, R. E et al.Cancer research (Baltimore). 1990, Vol 50, Num 14, pp 4377-4381, issn 0008-5472, 5 p.Article

Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cellsGRANT, A. J; MERCHANT, R. E; HALL, R. E et al.Immunology (Oxford). 1989, Vol 66, Num 1, pp 117-124, issn 0019-2805Article

Hairy cell leukemia. Ultrastructural and cytochemical evaluation of leukemic colonies grown in a semi-solid mediumMERCHANT, R. E; HOFMANN, V; MOREILLON, M.-C et al.European journal of cancer & clinical oncology. 1985, Vol 21, Num 2, pp 221-232, issn 0277-5379Article

Acute effects of human recombinant tumor necrosis factor-α on the cerebral vasculature of the rat in both normal brain and in an experimental glioma modelKIDO, G; WRIGHT, J. L; MERCHANT, R. E et al.Journal of neuro-oncology. 1991, Vol 10, Num 2, pp 95-109, issn 0167-594XArticle

Systemic treatment with murine recombinant interleukin-1β inhibits the growth and progression of malignant glioma in the ratRICE, C. D; MERCHANT, R. E.Journal of neuro-oncology. 1992, Vol 13, Num 1, pp 43-55, issn 0167-594XArticle

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomasCHI, D. D. J; MERCHANT, R. E; RAND, R et al.The American journal of pathology. 1997, Vol 150, Num 6, pp 2143-2152, issn 0002-9440Article

A comparison of the cardiopulmonary effects of continuous versus bolus infusion of recombinant interleukin-2 in sheepGLAUSER, F. L; DEBLOIS, G. G; BECHARD, D. E et al.Cancer research (Baltimore). 1988, Vol 48, Num 8, pp 2221-2225, issn 0008-5472Article

Cardiopulmonary effects of recombinant interleukin-2 infusion in sheepGLAUSER, F. L; DEBLOIS, G. G; BECHARD, D. E et al.Journal of applied physiology (1985). 1988, Vol 64, Num 3, pp 1030-1037, issn 8750-7587Article

Mitogen-activated lymphocytes of normals and glioma patients produce factors with anti-glioblastoma activity in vitroMERCHANT, R. E; FONTANA, A; NELSON, A. T. JR et al.Journal of neuroimmunology. 1986, Vol 11, Num 1, pp 1-14, issn 0165-5728Article

Leukoregulin inhibits the growth of human glioblastoma in vitroMERCHANT, R. E; RANSOM, J. H; YOUNG, H. F et al.Journal of neuroimmunology. 1986, Vol 13, Num 1, pp 31-45, issn 0165-5728Article

Effects of an intratumoral injection of human recombinant tumor necrosis factor-α on cerebrovascular permeability and leukocytic infiltration in a rat glioma modelWRIGHT, J. L; MERCHANT, R. E.Acta neuropathologica. 1997, Vol 93, Num 1, pp 78-86, issn 0001-6322Article

Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-α in the ratWRIGHT, J. L; MERCHANT, R. E.Journal of neuro-oncology. 1994, Vol 20, Num 1, pp 17-25, issn 0167-594XArticle

Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in ratsELLISON, M. D; MERCHANT, R. E.Journal of neuroimmunology. 1991, Vol 33, Num 3, pp 245-251, issn 0165-5728Article

Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma. CommentWATSS, R. G; MERCHANT, R. E; GILLESPIE, G. Y et al.Neurosurgery. 1992, Vol 31, Num 1, pp 89-99, issn 0148-396XArticle

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or combination with systemic interferon-α. Results of a phase I clinical trialMERCHANT, R. E; MCVICAR, D. W; MERCHANT, L. H et al.Journal of neuro-oncology. 1992, Vol 12, Num 1, pp 75-83, issn 0167-594XArticle

In vitro analysis of the proliferative potential of T cells from patients with brain tumor : glioma-associated immunosuppression unrelated to intrinsic cellular defectMCVICAR, D. W; DAVIS, D. F; MERCHANT, R. E et al.Journal of neurosurgery. 1992, Vol 76, Num 2, pp 251-260, issn 0022-3085Conference Paper

Low-abundance 32-kilodalton nuclear protein specifically enriched in the central nervous systemSHELTON, K. R; CUNNINGHAM, J. G; KLANN, E et al.Journal of neuroscience research. 1990, Vol 25, Num 3, pp 287-294, issn 0360-4012, 8 p.Article

Cardiorespiratory and cellular changes with interleukin 2 infusion in sheepGLAUSER, F. L; BECHARD, D. E; DEBLOIS, G. G et al.Journal of applied physiology (1985). 1989, Vol 66, Num 1, pp 128-134, issn 8750-7587Article

  • Page / 2